Stockreport

BioMarin Pharmaceutical (BMRN): Evaluating Valuation After Raised Guidance on Revenue Strength [Yahoo! Finance]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF BioMarin Pharmaceutical (BMRN) just posted quarterly revenues rising 4% to $776 million, matching Wall Street views. Growth was fueled by strong performance in PALYNZIQ [Read more]